Skip to main content
Sign In

91 percent response rate for venetoclax

Clinical trial results published in the journal Nature Medicine show 91 percent response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML).

Cancer hijacks the microbiome to glut itself on glucose

Cancer gets energy in the form of glucose. But how does it get this glucose? A recent study shows that leukemia undercuts the ability of normal cells to consume glucose, leaving more glucose available to feed its own growth.

Angelo D'Alessandro to become NBF Scholar

Angelo D’Alessandro, PhD, will be honored by receiving the title of National Blood Foundation Scholar next month for completing a study funded by an NBF early-career Scientific Research Grant in 2016.

Patients light the night to support blood cancer cures

Nathan Kissack figured he pulled a muscle while cutting hay for the cows on his ranch. Worried about his back, Kissack went to see a buddy who’s a chiropractor. The news was bad. An X-ray showed a large tumor right in the middle of Kissack’s chest.

 
​​​

Contact Info

General Hematology

Phone: 720.848.0300
1665 Aurora Court
Mailstop F-754
Aurora, CO 80045 
 

Blood Cancer & BMT

Phone: 720.848.6400
1665 Aurora Court
Mailstop F-754
Aurora, CO 80045 


Referring Providers

DocLine: 720-848-2828

Maps & Directions

 Su   Mo   Tu   We   Th   Fr   Sa 
      1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31      


 

Grand Rounds are on Tuesdays. Hover over the date for quick details. 

 
You can also see the​ full Calendar​

​ 

Highlights

  • Largest collection of blood disease experts in the Rockies.
  • Outstanding and compassionate care, the latest in new treatments, and cutting edge research.
  • We treat blood cancers such as leukemia, lymphoma, myeloma, myelodysplastic syndrome (MDS), and other blood problems such as anemia (including sickle cell disease), bleeding disorders (including hemophilia), and clotting disorders.
  • ...Read More.

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​